ALLO
Allogene Therapeutics, Inc. · Healthcare
EVP of R, D, CMO Rafael Amado sold $85K of Allogene Therapeutics, Inc.
Sold$85,092
$7.40Price
11,500Shares
−2%Stake
What ALLO did after the filing
- The stock from Fri, May 20 open, $7.57
- +53.0%
- S&P 500, same days
- −2.1%
Measured over 30 trading days, to the Jul 6 close.
Traded Thu, May 19. Filed Thu, May 19, 5:40 PM ET, after the close. Returns use the May 20 open and the Jul 6 close. Not investment advice.